rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Boehringer Ingelheim

Rediff.com  »  News  »   Boehringer Ingelheim

  News for Boehringer Ingelheim

  • Business

Cipla signs global supply deal with Boehringer

Indian pharmaceutical major Cipla has signed up a global supply deal with the $10 billion German drug maker Boehringer Ingelheim.The product development and manufacturing pact, which will be the......

US FDA tightens regulatory noose on Indian drug firms

Import alert on Ranbaxy’s Mohali unit; Strides’ injectible arm gets warning letter Indian drug makers have again come under the scrutiny of the US Food and Drug Administration (US FDA),......

Wockhardt launches prostate drug in US market

Pharma major Wockhardt on Wednesday said it has launched Tamsulosin capsules, indicated for problem of prostate enlargement, in the US market on the day one of the expiry of patent covering the......

Drug patent settlements to come under EU scanner

Patent settlements between pharmaceutical companies that make original drugs and their generic manufacturing rivals are to come under renewed scrutiny from the European Union's competition......

Meet Malav, the charismatic CEO of Ranbaxy

In the two years since becoming CEO, Malvinder Mohan Singh has systematically purged risk out of Ranbaxy's model. Malvinder Mohan Singh, 35, does not mind wearing a T-shirt in office - tucked in.......
  Web results for Boehringer Ingelheim
Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com

PRWeb 2015-05-22 In-demand research report Chronic Obstructive Pulmonary Disorder (COPD): KOL Insight created by FirstWord is now available at... ...

http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=408025
First FDA-Approved Biosimilar Brings Hope for CMO Growth

NEW YORK , May 22, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration's (FDA) recent approval of Zarxio (filgrastim-sndz) -- the first... ...

http://www.asianhhm.com/pressreleases/kalorama-first-fda-approved-biosimilar-brings-hope-for-cmo-growth
Boehringer Ingelheim acquires Pharmaxis' anti-inflammatory drug...

http://www.biospectrumasia.com/biospectrum/news/221289/boehringer-ingelheim-acquires-pharmaxis-anti-inflammatory-drug-candidate
Zealand Interim Report for Q1 2015 (unaudited) Increase in royalty revenue and progression of the development pipeline

-- Royalty revenue on Lyxumia(R) of DKK 6.3 million / EUR 0.8 million, an increase of 67% versus Q1 2014 -- Total revenues of DKK 6.3 million / EUR... ...

http://www.bizwireexpress.com/showstoryGNW.php?storyid=72283
TAUBE HODSON STONEX PARTNERS LLP ANNOUNCE 4.35% SHAREHOLDING IN ABLYNX

Comments May 22, 2015 - London REGULATED INFORMATION GHENT, Belgium, 22 May 2015 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced,... ...

http://andhranews.net/Business/2015/TAUBE-HODSON-STONEX-PARTNERS-LLP-ANNOUNCE-20728.htm

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


boehringer ingelheim
Boehringer Ingelheim

Company
0 Followers

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z